869 results on '"Howard, Scott C"'
Search Results
2. Tumour lysis syndrome
3. Expert consensus guidelines for the prophylaxis and management of tumor lysis syndrome in the United States: Results of a modified Delphi panel
4. Time to establish an international vaccine candidate pool for potential highly infectious respiratory disease: a community’s view
5. Pediatric Oncology Surgery: Research Methodology
6. Democracy and case fatality rate of COVID-19 at early stage of pandemic: a multicountry study
7. Impact of computerised physician order entry (CPOE) on the incidence of chemotherapy-related medication errors: a systematic review
8. Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study.
9. COVID-19 vaccine: Call for employees in international transportation industries and international travelers as the first priority in global distribution
10. Examining policy cohesion for cervical cancer worldwide: analysis of WHO country reports
11. Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey
12. Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity
13. Cancer Treatment in Low- and Middle-Income Countries
14. Contributors
15. Tumor Lysis Syndrome
16. Cancer epidemiology and the “incidence gap” from non-diagnosis
17. Early clinical indicators of acute kidney injury caused by administering high-dose methotrexate therapy to juvenile pigs
18. Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity.
19. Severe Methotrexate Toxicity Following a Capizzi Cycle in an Obese Adolescent With Acute Lymphoblastic Leukemia and Hepatic Steatosis.
20. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition
21. Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines
22. Oncologic Emergencies
23. Hematology and Oncology in Critical Illness
24. How should childhood acute lymphoblastic leukemia relapses in low‐income and middle‐income countries be managed: The AHOPCA‐ALL study group experience
25. Differentiation Scoring (DS) Derived from Cellworks Computational Omics Biology Model (CBM) Predicts Response to Hypomethylating Agents (HMA) and Patient Survival in Myelodysplastic Syndrome (MDS)
26. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review
27. Pregnancy-associated cardiomyopathy in survivors of childhood cancer
28. Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing
29. Multiple Asparaginase Infusions Cause Increasingly Severe Acute Hyperammonemia
30. Variations of COVID-19 mortality are affected by economic disparities across countries
31. New policies to address the global burden of childhood cancers
32. Paediatric cancer in low-income and middle-income countries
33. Safe Use of Low–Molecular-weight Heparin in Pediatric Acute Lymphoblastic Leukemia and Lymphoma Around Lumbar Punctures
34. Hepatoblastoma and Abernethy Malformation Type I: Case Report
35. Treatment-related mortality in children with acute myeloid leukaemia in Central America: Incidence, timing and predictors
36. Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia
37. Florence Nightingale Needs Your Attention: A Framework for Improving Pediatric Oncology Nursing in Low- and Middle-Income Countries
38. Safety and Immunogenicity of Live Attenuated and Inactivated Influenza Vaccines in Children With Cancer
39. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia
40. Global Neuroblastoma Network: An international multidisciplinary neuroblastoma tumor board for resource‐limited countries
41. Neurologic morbidity and quality of life in survivors of childhood acute lymphoblastic leukemia: a prospective cross-sectional study
42. A Framework for Adapted Nutritional Therapy for Children With Cancer in Low- and Middle-Income Countries: A Report From the SIOP PODC Nutrition Working Group
43. Improving Care for Children With Cancer in Low- and Middle-Income Countries—A SIOP PODC Initiative
44. How should childhood acute lymphoblastic leukemia relapses in low‐income and middle‐income countries be managed: The AHOPCA‐ALL study group experience.
45. Insights from a pharmacometric analysis of HDMTX in adults with cancer: Clinically relevant covariates for application in precision dosing.
46. Treating Childhood Cancer in Low- and Middle-Income Countries
47. Long-term sequelae and follow-up care in survivors of childhood acute lymphoblastic leukemia: A meta-analysis of treatment-related late-effects
48. Therapy Biosimulation Using the Cellworks Computational Omics Biology Model (CBM) Is Predictive of Individual Acute Myeloid Leukemia (AML) Patient Probability of Clinical Response (CR) and Overall Survival (OS): Mycare-023
49. Biosimulation Using the Cellworks Computational Omics Biology Model (CBM) Identifies Immune Modulation As a Key Pathway for Predicting Azacitidine (AZA) Response in Myelodysplastic Syndromes (MDS)
50. Biosimulation Using the Cellworks Computational Omics Biology Model (CBM) Predicted Novel Biomarkers for Hyper-CVAD (CVAD) Treatment Response and Combination of Rituximab and Cladribine (RC) in CVAD Resistant Cases of Mantle Cell Lymphoma (MCL)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.